https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, September 26, 2022


Published: Friday, September 23, 2022

OUHSC Research News – Monday, September 26, 2022

Notices and Reminders

ORA Reminder for Principal Investigators and Their Support Teams

Please ensure that all key personnel on your project complete their Compliance Forms in SoonerTrack as soon as you submit your Request Form in the system. Your Request Form is not considered received by ORA if Compliance Forms are not approved by all key personnel. This can cause a delay in submitting your proposal to the funding agency and potentially a risk of missing the submission deadline.

Principal Investigators (and their support teams) retain primary responsibility for ensuring that all these approvals are complete before the deadline. So, please check the status of your Key personnel’s Compliance Forms after submitting your proposal in SoonerTrack to ensure a smooth submission process.

 

IMPORTANT SOONERTRACK UPDATE: Off-Campus Access to SoonerTrack II

The Office of Research Administration (ORA) is excited to announce that SoonerTrack II is now accessible off-campus through Self-Service at: selfservefs.ou.edu. As a result, you will not need to use the GlobalProtect VPN (Virtual Private Network) or MyDesk VDI service (Virtual Desktop Infrastructure) when off-campus to access the SoonerTrack II system. However, DUO dual authentication is still required. Please note that mobile devices such as cell phones are not fully compatible at this time. If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

 

OUHSC Research News is intended to notify faculty and staff of new funding opportunities, upcoming workshops and seminars, agency updates, and OUHSC policies and procedures that impact sponsored research. If your department or unit has an open funding opportunity or is offering a workshop event that you’d like to be included in the newsletter, please send it to the Office of Research Administration (ORA) at oradmin@ouhsc.edu. Items for the newsletter should be received by the ORA on later than 5:00 PM on Thursday to be included in the following week’s issue.   

 

Upcoming Grants.gov Downtime, September 23-29, 2022

Grants.gov will be migrating to the cloud, resulting in a period of planned downtime for the website. The migration will begin Friday September 23, 2022 at 12:01 AM ET, and end on Thursday September 29, 2022 at 11:59 PM ET. During that period, Grants.gov will be unavailable to users. To mitigate the impact, NIH due dates that fall on or between Thursday, September 22 and Friday, September 30, 2022 will move to October 3, 2022. Let’s look at a few scenarios for applications targeting an impacted due date and how the application viewing window comes into play.

Scenario 1

Applicant submits an application on Wednesday, September 20, for an impacted due date and receives a notification from eRA Commons that errors were identified.

  • Applications must be error-free before an application image is generated and placed in eRA Commons. Viewing window does not apply.
  • A corrective application addressing the errors must be submitted by 5 PM on October 3.

Scenario 2

Applicant submits an error-free application on Wednesday, September 20, for an impacted due date and receives a notification from eRA Commons that the assembled application is available for viewing. They view the application in eRA Commons and like what they see.

  • No action needed. At midnight ET on Friday, the application viewing window will close and the application will move to receipt and referral staff for further processing.

Scenario 3

Applicant submits an error-free application on Wednesday, September 20, for an impacted due date and receives a notification from eRA Commons that the assembled application is available for viewing. Upon viewing the application they find the latest Research Strategy was not included and they want to make a corrective submission prior to the deadline.

  • The viewing window for applications submitted on Wednesday, September 20, would be Thursday and Friday.
  • Applicant has two possible options:
    • Submit a corrective application on Thursday (prior to Grants.gov downtime on Friday).
    • Reject the application in eRA Commons to prevent it from moving forward and submit a corrective application by 5 PM on October 3.

Scenario 4

Applicant submitted an application for an impacted due date. After the application viewing window in eRA Commons and during the Grants.gov downtime, they discovered a substantive issue with the application they want to correct prior to the extended due date.

  • The applicant can officially withdraw the application from processing and submit a corrective application by 5 PM on October 3.

 

ORA Notice: The Office of Research Administration (ORA) is pleased to provide to our faculty and staff the training videos focused on the compliance topics listed below. These trainings were offered as part of a “Compliance and Research Workshop” to ensure that the OUHSC research community was appropriately informed of the various regulations that govern federally-funded research. To access the videos and download the slides, please click here.  

  • Office of Compliance   
  • Export Controls and Foreign Influence
  • The False Claims Act 
  • Intellectual Property at the University of Oklahoma
  • Office of Human Research Participant Protection (HRPP) and Institutional Review Board (IRB) 

 

Workshops and Seminars

OUHSC and OU-Norman combined Bioinformatics Mini-Symposium

A mini-symposium is being planned on the OU-Norman to bring together Bioinformatics and Computational Biology researchers from both the OU-Norman and OUHSC campuses. The goal of this mini-symposium is to establish collaborations between OUHSC researchers performing Omics analyses with the Informatics Department at OU-Norman so that together we can build a highly skilled workforce for analyses of R and Python based Omics technologies, including single cell RNA sequencing and spatial transcriptomics. At the symposium, we will highlight current work being done in the single cell Omics field at OUHSC and provide an overview of how high-end computational approaches to Omics could further biomedical research projects on both campuses. Overall, we aim to foster collaboration in research and education, increase the understanding of state-of-the-art Omics tools and techniques, and explore avenues for increasing our bioinformatics and computationally skilled workforce to support Bioinformatics/Computer Biology analyses on the OUHSC and OU-Norman campuses.  If you are currently performing Omics research, plan to perform Omics research, or are interested in learning about Omics research, please contact either darrin-akins@ouhsc.edu or james-papin@ouhsc.edu for further information as we set a date for the symposium planned for this fall.

 

The Office of Technology Commercialization Lunch and Learn - Copyright, Trademark and Open Source

Date/Time: September 28, 2022 12:00 PM Central Time

Description: We invite you to join us for an upcoming session of Innovation to Impact, a series of lunch discussions for faculty, staff and graduate students about the creation, management and commercialization of intellectual property (IP).

Copyright, Trademark & Open Source

  • Not all intellectual property is patentable
  • Filing for copyrights and trademarks
  • Protecting your software application
  • Examples of licensing non-traditional IP

During these presentations, you will learn more about the impact of IP and how it complements your research.

Registration link: Space is limited, so participants must register.

 

NIH Webinar: Research Misconduct & Detrimental Research Practices Webinar

Date: October 14, 2022, 2:10 PM – 3:15 PM EST

Description: What is research misconduct and what are some detrimental research practices? Research Integrity Officers from the Office of Research Integrity (ORI), HHS and NIH will help answer this question and more, as they discuss Public Health Service (PHS) regulations on handling research misconduct allegations, responsibilities of an institution receiving PHS funds, and red flags that may help to avoid misconduct in research. Experts will explore interpersonal, institutional, and professional responsibilities in the overall ethical conduct of research during presentations, case studies, and discussions with the audience. Registration is free and includes access for the NIH Grants Conference 2022-2023 season.

Registration link: https://grants.nih.gov/learning-center/conference/precon-events/research-misconduct

 

Team building and research development for projects in health, well-being, and the built environment (Workshop 2 of 2)

Date/Time: Friday, October 21, 9:00 a.m. -12:00 pm Central

One sentence summary of the event:  This second of two interactive workshops has OU Norman and OU HSC researchers pitch their collaborative research ideas and participate in activities to further trans-disciplinary aspects and align with funding opportunities in the area of health, well-being, and the built environment.

Description: Join CFE, along with Susan Sisson (Allied Health) and Angela Person (Gibbs College), in the second of two workshops to further develop ideas for collaborative proposals related to health, well-being, and the built environment. Participation in both workshops is not required, but suggested.

During this session, OU researchers will share the basic idea of their team research, receive feedback from grant writing experts, develop a plan to reach out to program managers, and further prepare for the internal seed grant funding opportunity aimed at securing external funding in the future. Don't have something to pitch or didn't attend the first workshop? Faculty from OU Norman and OU HSC are encouraged to attend to learn more.

Event Venue/Location: In-person on the OU Norman campus. Location information follows registration

Registration link: https://ousurvey.qualtrics.com/jfe/form/SV_bjgGl4HK21Fr14i

RFP: https://bit.ly/3R8Prc4

Point of contact: Clara Smith, clara.smith@ou.edu [same person as for workshop 1]

 

OUHSC Funding Opportunities

Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit

Description: Grant proposals are being accepted for the Fall cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $125,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Submission Checklist provided with this notice.

Deadline: October 3, 2022 at 5 pm CST

Link to the full announcement or a flyer: Please refer to the attached flyer.

 

Harold Hamm Diabetes Center (HHDC) Research Symposium Call for Abstracts 

Deadline for Abstract submission for the HHDC 2022 Research Symposium: Friday, September 30, 2022. Abstracts must be received by 5 p.m.

HHDC 2022 Research Symposium will be held on Friday, November 11, 2022 at the Samis Education Center in Children’s Hospital in Oklahoma City.  The Symposium will consist of selected oral presentations, and a keynote address by Alvin C. Powers, MD, Joe C. Davis Chair in Biomedical Science, Medicine, and Molecular Physiology and Biophysics Professor, Vanderbilt Diabetes Center Director, Division of Diabetes and Endocrinology, Vanderbilt University. For abstract submission guidelines and to RSVP for this free event, please go to:

https://www.ouhealth.com/harold-hamm-diabetes-center/diabetes-research/diabetes-lectures-seminars-visiting-professorshi/diabetes-research-symposium/

Please contact lark-zink@ouhsc.edu with any questions for this event.

 

 NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities 

 

Other Funding Opportunities

Call for Pre-Proposals National Cancer Institute Predoctoral to Post-Doctoral Fellow Transition Award (F99/K00)

Description: OUHSC can nominate one graduate student in their 3rd or 4th year since beginning graduate school who is working towards their PhD degree to apply for an F99/K00 award from the NCI (https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-041.html).  Note: Dual-degree, or professional doctorate/clinical degree students are not eligible.

  1. Purpose:  The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments, and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. Final F99/K00 application due date at NIH is November 19, 2022.
  2. Eligibility:  3rd or 4th year graduate student working on a specific cancer-related Ph.D. dissertation project that wants to transition in the next 1-2 years to a postdoctoral fellowship research in cancer research.
  3. Submitting a pre-proposal:  A pre-proposal must be submitted to the SCC Education and Training Core by October 7, 2022.

Pre-proposals must include:

  1. Specific Aims Page: there are 2 required Specific Aims as follow:
    1. Aim 1: The Dissertation Research Project
    2. Aim 2: The Postdoctoral Research Direction
  2. Letter of support from F99 sponsor(s)
  3. Full CV of applicant including academic record and prior research experience
  4. NIH Biosketch of sponsor(s)
  1. Submit the pre-proposal as a single file in PDF format to:  Stevie-Warner@ouhsc.edu.
  2. Pre-proposals will be reviewed by a panel of expert cancer researchers and educators.

 

Alzheimer's Drug Discovery Foundation Core Requests for Proposals

Description: Core Funding Programs now accepting applications for the following programs:

  • PROGRAM TO ACCELERATE CLINICAL TRIALS (PACT)
    Up to $3 Million in Funding
    Funds IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease and related dementias
  • DRUG DISCOVERY
    Supports programs advancing molecules to IND-enabling studies.
  • NEUROIMAGING AND CSF BIOMARKER DEVELOPMENT
    Supports the development and validation of CSF and neuroimaging biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging.
  • PREVENTION BEYOND THE PIPELINE
    Supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

Letter of Intent deadline: September 30, 2022
Link to Full Announcement: http://www.alzdiscovery.org/research-and-grants/funding-opportunities

 

The Natural Hazards Center (NHC) - Special Call for Proposals: Research in U.S. Territories, Tribal Areas, and Rural Communities

Description: The Natural Hazards Center (NHC)—with support from the Centers for Disease Control and Prevention (CDC) and the National Science Foundation (NSF)—is issuing a special call for proposals focused on studying public health preparedness, response, and resilience to disasters in the inhabited U.S. territories of American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands, tribal areas, and rural communities across the United States.

Research is urgently needed to develop evidence-based practices to improve community preparedness, resilience, and the public health response to disasters in these regions. While these areas are historically, geographically, socially, and culturally unique, they are at higher risk to adverse disaster impacts—including deaths and property loss—than many other regions of the United States. This special call is designed to address these gaps in knowledge.

Proposals and Pre-submission Requirements: due by 5:00 p.m. MT on Friday, October 7, 2022

Link to Full Announcement: https://hazards.colorado.edu/research/research-in-US-territories-tribal-areas-and-rural-communities 

 

ASPIRE: A Supplement to Promote Inclusion for Research Excellence

Description: Despite progress in breast cancer research and patient care, not everyone is benefitting from the scientific advances and improvements in breast cancer care and outcomes.  This new Susan G. Komen grant is intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. A breast cancer research workforce that represents the breast cancer community is one way to work towards health equity and better outcomes for all. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever. 

Eligibility: Lead mentor must have a currently funded breast cancer research project that has undergone a rigorous peer review by either Susan G. Komen, the Department of Defense, the National Institutes of Health (NIH) or the National Science Foundation (NSF). Trainees supported by this supplement must be from one or more the following racial and ethnic groups that have been shown to be underrepresented in biomedical research, as per data from the 2021 US National Science Foundation report on Women, Minorities, and Persons with Disabilities in Science and Engineering:  Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islander. (https://diversity.nih.gov/about-us/population-underrepresented). Supported trainees may include predoctoral students (post qualifying exam), health professional students, and postdoctoral fellows.

Award amount: up to $80,000 per year to cover a trainee’s salary for one year or two years.

Full Application Due: November 1, 2022, by 1 p.m., Eastern Standard Time

Link to Full Announcement: https://bit.ly/3xmfvcn

 

Melanoma Research Alliance (MRA) - 2022-2023 Request for Proposals

Description: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

Proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards. Special Opportunities Included in RFP:

  • Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS)
  • Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
  • Metastatic Uveal Melanoma Pilot Award co-funded with A Cure in Sight
  • Patient-Centric Clinical Trials Team Science Awards co-funded with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) 

Deadline for Letters of Intent for RTFCCR-MRA Team Science Awards: October 5, 2022

Deadline for Young Investigator applicants to submit Applicant Eligibility Checklist: October 19, 2022

Deadline for all Individual Awards (EIA, YIA, and Pilot) proposals: November 2, 2022

Deadline for invited full applications for RTFCCR-MRA Team Science Awards: January 18, 2023

Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/mra-general-rfp/

 

 The International Center for Responsible Gaming - ICRG Center of Excellence for Gambling Research

Description: The purpose of this funding opportunity is to advance development, implementation and validation of interventions to minimize gambling-related harm through responsible gambling programs. The ICRG is especially interested in understanding and addressing the low usage of responsible gambling tools. Applicants may request up to $402,500 for a three-year grant.

Application Deadline: October 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

Documents to download